Patents Assigned to Tulark Inc.
  • Arylsulfonanilide ureas
    Publication number: 20030207864
    Abstract: The invention provides compounds, compositions and methods relating to novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia, or as lead compounds for the development of such agents.
    Type: Application
    Filed: March 11, 2003
    Publication date: November 6, 2003
    Applicant: Tulark Inc.
    Inventor: Jonathan B. Houze